Amylyx Pharmaceuticals, Inc. Common Stock (AMLX)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
33. 81
+0.06
+0.1778%
$
3.75B Market Cap
- P/E Ratio
- Div Yield
1.82M Volume
- Eps
$ 33.75
Previous Close 
Want to track AMLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Amylyx Pharmaceuticals, Inc. Common Stock Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Andrew S. Fein HC Wainwright & Co. | 5,613.83 | $197,101.73 | $216,694.02 | $19,592.29 | 9.94% |
 Joel Beatty Baird | 8,947.99 | $345,392.28 | $345,392.28 | - | - |
